Coronavirus disease 2019 (COVID-19) and decrease in blood donation: experience of Iranian Blood Transfusion Organization (IBTO).
作者信息
Mohammadi Saeed, Tabatabaei Yazdi Seyed Morteza, Eshghi Peyman, Norooznezhad Amir Hossein
机构信息
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
出版信息
Vox Sang. 2020 Oct;115(7):595-596. doi: 10.1111/vox.12930. Epub 2020 Apr 20.
Abstract
摘要
相似文献
1
Coronavirus disease 2019 (COVID-19) and decrease in blood donation: experience of Iranian Blood Transfusion Organization (IBTO).2019冠状病毒病（COVID-19）与献血量减少：伊朗输血组织（IBTO）的经验
Vox Sang. 2020 Oct;115(7):595-596. doi: 10.1111/vox.12930. Epub 2020 Apr 20.
2
The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization.重复献血对参加伊朗输血组织的伊朗献血者铁状态的影响。
Int J Vitam Nutr Res. 2006 May;76(3):132-7. doi: 10.1024/0300-9831.76.3.132.
3
Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience.血浆成分分离，一种改善国家输血系统和血液安全的有用方法：伊朗的经验。
Haemophilia. 2009 Mar;15(2):487-93. doi: 10.1111/j.1365-2516.2008.01936.x.
4
Four decades of National Blood Service in Iran: outreach, prospect and challenges.伊朗国家血液服务四十年：拓展、前景与挑战
Transfus Med. 2015 Jun;25(3):138-43. doi: 10.1111/tme.12214. Epub 2015 Jun 4.
5
A successful experience of the Iranian blood transfusion organization in improving accessibility and affordability of plasma derived medicine.伊朗输血组织在提高血浆衍生药物可及性和可负担性方面的成功经验。
Transfus Apher Sci. 2017 Feb;56(1):12-16. doi: 10.1016/j.transci.2016.12.009. Epub 2017 Jan 4.
6
Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.伊朗献血者中乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒和人类嗜 T 淋巴细胞病毒的流行趋势和流行病学分析：提高血液安全性的策略。
BMC Infect Dis. 2020 Oct 7;20(1):736. doi: 10.1186/s12879-020-05405-9.
7
COVID-19 transmission and blood transfusion: A case report.COVID-19 传播与输血：病例报告。
J Infect Public Health. 2020 Nov;13(11):1678-1679. doi: 10.1016/j.jiph.2020.05.001. Epub 2020 May 13.
8
Organization of the outdoor blood donation drives amid novel coronavirus pandemic and national lockdown: An experience from a tertiary care oncology institution in India.新型冠状病毒大流行和全国封锁期间户外献血活动的组织：来自印度一家三级肿瘤护理机构的经验。
Transfus Apher Sci. 2020 Oct;59(5):102878. doi: 10.1016/j.transci.2020.102878. Epub 2020 Jul 15.
9
Meeting the Challenges of International Crises: The Experience of the Iranian Blood Transfusion Organization.应对国际危机的挑战：伊朗输血组织的经验。
Disaster Med Public Health Prep. 2019 Jun;13(3):410-413. doi: 10.1017/dmp.2018.71. Epub 2018 Aug 1.
10
引用本文的文献
1
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19.自然灾害、人道主义紧急情况和大流行病期间的血液供应管理：从 COVID-19 中吸取的教训。
Expert Rev Hematol. 2023 Jul-Dec;16(7):501-514. doi: 10.1080/17474086.2023.2209716. Epub 2023 May 9.
2
Blood supply management amid COVID 19 pandemic: Challenges and strategies.新冠疫情期间的血液供应管理：挑战与策略
J Family Med Prim Care. 2022 Jun;11(6):2363-2368. doi: 10.4103/jfmpc.jfmpc_701_21. Epub 2022 Jun 30.
3
Evaluating the Importance of Patient Blood Management During COVID-19 Pandemic.评估2019冠状病毒病大流行期间患者血液管理的重要性。
Anesth Pain Med. 2022 Jan 1;11(6):e112910. doi: 10.5812/aapm.112910. eCollection 2021 Dec.
4
The Impact of COVID-19 on Blood Transfusion Services: A Systematic Review and Meta-Analysis.2019年冠状病毒病对输血服务的影响：系统评价与荟萃分析
Transfus Med Hemother. 2021 Nov 16;30(2):1-12. doi: 10.1159/000519245.
5
Motivation, blood donor satisfaction and intention to return during the COVID-19 pandemic.在 COVID-19 大流行期间的动机、献血者满意度和再次献血意愿。
Vox Sang. 2022 Apr;117(4):488-494. doi: 10.1111/vox.13212. Epub 2021 Nov 2.
6
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios.新冠疫情期间的费城染色体阴性慢性骨髓增殖性肿瘤：挑战与未来展望
Cancers (Basel). 2021 Sep 23;13(19):4750. doi: 10.3390/cancers13194750.
7
A novel capacity sharing mechanism to collaborative activities in the blood collection process during the COVID-19 outbreak.一种在新冠疫情期间血液采集过程中用于协作活动的新型容量共享机制。
Appl Soft Comput. 2021 Nov;112:107821. doi: 10.1016/j.asoc.2021.107821. Epub 2021 Aug 13.
8
Management of children with glucose-6-phosphate dehydrogenase deficiency presenting with acute haemolytic crisis during the SARs-COV-2 pandemic.严重急性呼吸综合征冠状病毒 2 流行期间葡萄糖-6-磷酸脱氢酶缺乏症儿童急性溶血性危象的管理。
Vox Sang. 2022 Jan;117(1):80-86. doi: 10.1111/vox.13123. Epub 2021 Jun 8.
9
Could COVID-19 Reverse the Modest Gains Made in Newborn Health in Ethiopia?COVID-19 会使埃塞俄比亚在新生儿健康方面取得的微小进展发生逆转吗？
Matern Child Health J. 2021 Jun;25(6):849-854. doi: 10.1007/s10995-021-03175-7. Epub 2021 May 3.
10
Blood Donations and Transfusions during the COVID-19 Pandemic in Spain: Impact According to Autonomous Communities and Hospitals.COVID-19 大流行期间西班牙的献血和输血：按自治区和医院划分的影响。
Int J Environ Res Public Health. 2021 Mar 27;18(7):3480. doi: 10.3390/ijerph18073480.
本文引用的文献
1
Meeting the Challenges of International Crises: The Experience of the Iranian Blood Transfusion Organization.应对国际危机的挑战：伊朗输血组织的经验。
Disaster Med Public Health Prep. 2019 Jun;13(3):410-413. doi: 10.1017/dmp.2018.71. Epub 2018 Aug 1.
Zotero 插件